Centre hospitalier Saint Louis

La Rochelle 17019

1 studies enrolling now · 3 studies all time

What they study most

Coronary Artery Disease, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Urothelial Carcinoma

Studies at this site

• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) — Recruiting now
• A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer — Running, not enrolling
• The Dual Antiplatelet Therapy Study (DAPT Study) — Completed